Sijunzi decoction granules for the treatment of advanced refractory colorectal cancer: study protocol for a multicenter, randomized, double-blind, placebo-controlled trial
The trial was registered at Chinese Clinical Trial Registry, http://www.chictr.org.cn (Registration No: ChiCTR2200065434); Date: 2022-11-04.
Authors
- Guang Ji (ORCID: https://orcid.org/0000-0003-0842-3676)
- Yanhua Jing
- Yi Zhong (ORCID: https://orcid.org/0000-0002-7138-5302)
- Hanchen Xu (ORCID: https://orcid.org/0000-0003-2335-5421)
- Lan Zheng (ORCID: https://orcid.org/0009-0007-3326-6656)
- Lu Lu (ORCID: https://orcid.org/0000-0002-9457-0164)
- Tingting Wu (ORCID: https://orcid.org/0000-0002-9612-0124)
- Hao Wu (ORCID: https://orcid.org/0000-0003-3083-2345)
- Yu‐Wen Su (ORCID: https://orcid.org/0000-0001-6730-8219)
- Junming Chen (ORCID: https://orcid.org/0000-0002-2005-3471)
- Zhi Jiang (ORCID: https://orcid.org/0000-0002-8844-3134)
- Ming Ruan
- Yabin Gong (ORCID: https://orcid.org/0000-0002-6811-101X)
- Shuchang Nie
- Liyu Wang
- Yangxian Xu
Institutions
- Shanghai Jiao Tong University (CN)
- Fudan University (CN)
- Ruijin Hospital (CN)
- Shanghai University of Traditional Chinese Medicine (CN)
- Minhang District Central Hospital (CN)
- Longhua Hospital Shanghai University of Traditional Chinese Medicine (CN)
- Yueyang Hospital (CN)
Publication Details
- Journal
- Frontiers in Medicine
- Published
- 2025-03-20
- DOI
- https://doi.org/10.3389/fmed.2025.1523913
- Citations
- 3
- Primary Topic
- Ginseng Biological Effects and Applications
- Type
- article
- Field-Weighted Citation Impact
- 2.42